Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) EPS (Weighted Average and Diluted): 2015-2025

Historic EPS (Weighted Average and Diluted) for AC Immune (ACIU) over the last 5 years, with Sep 2025 value amounting to -$0.20.

  • AC Immune's EPS (Weighted Average and Diluted) fell 446.58% to -$0.20 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.38, marking a year-over-year increase of 23.91%. This contributed to the annual value of -$0.58 for FY2024, which is 19.31% up from last year.
  • AC Immune's EPS (Weighted Average and Diluted) amounted to -$0.20 in Q3 2025, which was down 9.51% from -$0.18 recorded in Q4 2024.
  • In the past 5 years, AC Immune's EPS (Weighted Average and Diluted) ranged from a high of $0.06 in Q3 2024 and a low of -$0.20 during Q3 2023.
  • In the last 3 years, AC Immune's EPS (Weighted Average and Diluted) had a median value of -$0.18 in 2024 and averaged -$0.12.
  • As far as peak fluctuations go, AC Immune's EPS (Weighted Average and Diluted) surged by 128.32% in 2024, and later plummeted by 446.58% in 2025.
  • AC Immune's EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.06 in 2023, then plummeted by 224.02% to -$0.18 in 2024, then slumped by 446.58% to -$0.20 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at -$0.20 for Q3 2025, versus -$0.18 for Q4 2024 and $0.06 for Q3 2024.